Ads
related to: bristol-myers squibb- Savings Card
See If You Are Eligible To Save
On An ELIQUIS Prescription
- ELIQUIS & Safety Info
See Full Safety Info &
Boxed Warning. Learn More
- Chat With Elise
Get Help From Our
Virtual Assistant, Elise
- Prescribing Info
See Full Prescribing Info
Including Boxed Warning
- ELIQUIS HCP Info
Visit the Official US Healthcare
Website for ELIQUIS Safety Info
- Doctor Discussion Guide
Learn More About The Interactive
Eliquis Doctor Discussion Guide
- Savings Card
scbn.org has been visited by 10K+ users in the past month
Search results
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 1 day agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...
Ajax, aiming for a better JAK drug, raises $95M to begin first tests
BioPharma Dive via Yahoo Finance· 1 day agoGoldman Sachs and Eli Lilly are among those backing the startup, which claims its prospect could be...
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Motley Fool via Yahoo Finance· 5 days agoAfter steadily raising its payout by 163% over the past 15 years, Pfizer (NYSE: PFE) continues to be...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 5 days agoNeurocrine Biosciences is making good on its promise to diversify from its blockbuster drug...
Veeva and H&E Equipment Services have been highlighted as Zacks Bull and Bear of the Day
Zacks· 1 day agoMay 13, 2024 – Zacks Equity Research shares Veeva Systems (VEEV Quick QuoteVEEV - Free Report) as the Bull of the Day and H&E Equipment Services, Inc. (HEES Quick QuoteHEES - Free Report) as ...
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields -...
Benzinga· 4 days agoLoading... Loading... During times of turbulence and uncertainty in the markets, many investors turn...
David Braun, MD, PhD, on Biomarkers in Renal Cell Carcinoma
MedPage Today· 24 hours agoFor patients with metastatic renal cell carcinoma (RCC), there are as yet no reliable biomarkers to...
Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoEditas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript May 8, 2024 Editas Medicine,...
India's Dr Reddy's expects healthy products pipeline in North America for FY25
Reuters· 7 days ago, opens new tab expects a healthy products pipeline in its key North American market in the fiscal year 2024-25, the generic drugmaker said on Tuesday, after it reported a fourth-quarter profit ...
Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
Zacks· 5 days agoFree Report) reported a loss of $1.34 per share in first-quarter 2024, wider than the Zacks...
Ad
related to: bristol-myers squibb